A Criterion-based Approach for the Systematic and Transparent Extrapolation of Clinical Trial Survival Data

by Gabriel Tremblay, Patrick Haines, Andrew Briggs

Enhancing the Value of the ASCO Value Framework

by Alec Morton, Peter B. Bach, Andrew Briggs
Published 2018-05-01

How Do Diabetes Models Measure Up? A Review of Diabetes Economic Models and ADA Guidelines

by Lindsay Govan, Olivia Wu, Robert Lindsay, Andrew Briggs

How methodological frameworks are being developed: evidence from a scoping review

by Nicola McMeekin, Olivia Wu, Evi Germeni, Andrew Briggs
Published 2020-06-01

Hospital expenditure at the end-of-life: what are the impacts of health status and health risks?

by Claudia Geue, Paula Lorgelly, James Lewsey, Carole Hart, Andrew Briggs
Published 2015-01-01

The impact of moderate and severe asthma exacerbations on quality of life: a post hoc analysis of randomised controlled trial data

by Andrew Briggs, Shuaib Nasser, Eva Hammerby, Sarah Buchs, J. Christian Virchow
Published 2021-01-01

Using Nominal Group Technique to Identify Key Attributes of Oncology Treatments for a Discrete Choice Experiment

by Camilla Somers, Susan Chimonas, Emma McIntosh, Anna Kaltenboeck, Andrew Briggs, Peter Bach
Published 2019-03-01

Cost-effectiveness of umeclidinium compared with tiotropium and glycopyrronium as monotherapy for chronic obstructive pulmonary disease: a UK perspective

by Dhvani Shah, Maurice Driessen, Nancy Risebrough, Timothy Baker, Ian Naya, Andrew Briggs, Afisi S. Ismaila
Published 2018-05-01

Mendelian randomization: estimation of inpatient hospital costs attributable to obesity

by Katherine Dick, John E. Schneider, Andrew Briggs, Pascal Lecomte, Stephane A. Regnier, Michael Lean
Published 2021-05-01

Health related quality of life utility weights for economic evaluation through different stages of chronic kidney disease: a systematic literature review

by Jacie T. Cooper, Andrew Lloyd, Juan Jose Garcia Sanchez, Elisabeth Sörstadius, Andrew Briggs, Phil McFarlane
Published 2020-09-01

Joint Assessment of Intended and Unintended Effects of Medications: An Example Using Vascular Endothelial Growth Factor Inhibitors for Neovascular Age-Related Macular Degeneration

by Adrian R. Levy, Shelagh Szabo, Andrew Briggs, Andreas Pleil, Alison Davie, Gergana Zlateva, Jonathan Javitt
Published 2009-01-01

Cost-effectiveness analysis of a single-inhaler triple therapy for patients with advanced chronic obstructive pulmonary disease (COPD) using the FULFIL trial: A UK perspective

by Melanie Schroeder, Dhvani Shah, Nancy Risebrough, Alan Martin, Shiyuan Zhang, Kerigo Ndirangu, Andrew Briggs, Afisi S. Ismaila
Published 2019-01-01

A Cost-effectiveness Analysis of Brentuximab Vedotin in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma

by Margaret Hux, Denise Zou, Esprit Ma, Peter Sajosi, Andreas Engstrom, Ross Selby, Eugene Benson, Andrew Briggs, Vijayveer Bonthapally

Ankylosing Spondylitis Patients Commencing Biologic Therapy Have High Baseline Levels of Comorbidity: A Report from the Australian Rheumatology Association Database

by John Oldroyd, Lionel Schachna, Rachelle Buchbinder, Margaret Staples, Bridie Murphy, Molly Bond, Andrew Briggs, Marissa Lassere, Lyn March
Published 2009-01-01

The SCottish Alcoholic Liver disease Evaluation: A Population-Level Matched Cohort Study of Hospital-Based Costs, 1991-2011.

by Janet Bouttell, James Lewsey, Claudia Geue, Grace Antony, Andrew Briggs, Gerry McCartney, Sharon Hutchinson, Lesley Graham, Mathis Heydtmann
Published 2016-01-01

Methodology of a Novel Risk Stratification Algorithm for Patients with Multiple Myeloma in the Relapsed Setting

by Walter Bouwmeester, Andrew Briggs, Ben van Hout, Roman Hájek, Sebastian Gonzalez-McQuire, Marco Campioni, Lucy DeCosta, Lucie Brozova
Published 2019-11-01

Novel risk stratification algorithm for estimating the risk of death in patients with relapsed multiple myeloma: external validation in a retrospective chart review

by Roman Hájek, Sebastian Gonzalez-McQuire, Zsolt Szabo, Michel Delforge, Lucy DeCosta, Marc S Raab, Walter Bouwmeester, Marco Campioni, Andrew Briggs
Published 2020-07-01

Cost-effectiveness of oral versus intravenous antibiotics (OVIVA) in patients with bone and joint infection: evidence from a non-inferiority trial [version 3; peer review: 2 approv...

by Nicola McMeekin, Claudia Geue, Andrew Briggs, Ines Rombach, Ho Kwong Li, Philip Bejon, Martin McNally, Bridget L. Atkins, Jamie Ferguson, Matthew Scarborough, OVIVA collaborators
Published 2019-12-01

Cost-effectiveness of oral versus intravenous antibiotics (OVIVA) in patients with bone and joint infection: evidence from a non-inferiority trial [version 4; peer review: 2 approv...

by Nicola McMeekin, Claudia Geue, Andrew Briggs, Ines Rombach, Ho Kwong Li, Philip Bejon, Martin McNally, Bridget L. Atkins, Jamie Ferguson, Matthew Scarborough, OVIVA collaborators
Published 2020-01-01

Enhancing Health Through Access to Nature: How Effective are Interventions in Woodlands in Deprived Urban Communities? A Quasi-experimental Study in Scotland, UK

by Catharine Ward Thompson, Aldo Elizalde, Steven Cummins, Alastair H. Leyland, Willings Botha, Andrew Briggs, Sara Tilley, Eva Silveirinha de Oliveira, Jenny Roe, Peter Aspinall, Richard Mitchell
Published 2019-06-01